Literature DB >> 22217744

Chronology of metastasis in cutaneous melanoma: growth rate model.

Antonio Tejera-Vaquerizo1, Eduardo Nagore, Juan J Meléndez, Norberto López-Navarro, Antonio Martorell-Calatayud, Enrique Herrera-Acosta, Victor Traves, Carlos Guillén, Enrique Herrera-Ceballos.   

Abstract

In humans, it is not possible to obtain experimental evidence of when a cancer begins to metastasize. The purpose of this study was to estimate the time of onset of metastatic dissemination in cutaneous melanoma using a model based on its growth rate (GR). The critical time of onset of metastatic dissemination below which no cases of fatal melanomas were seen may be described with a potential function in which this time is inversely proportional to the GR. The critical time of development beyond which a melanoma may metastasize presents great variation. This time was just 1 month for those melanomas with a fast GR, whereas it was over 5 years for those with a very slow GR. Quantitatively, the fastest-growing melanomas began metastasizing with a greater thickness than the slowest-growing melanomas. A correlation exists between the critical time of onset of metastatic potential and the GR of the melanoma. These results may well have relevance to the understanding of mechanisms of tumor dissemination and for the design of future studies on melanomas, irrespective of whether they are basic studies on biomolecular mechamisms or clinical studies.

Entities:  

Mesh:

Year:  2012        PMID: 22217744     DOI: 10.1038/jid.2011.433

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model.

Authors:  A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore
Journal:  Actas Dermosifiliogr       Date:  2020-09-20

2.  Risk Factors for Lymphatic and Hematogenous Dissemination in Patients With Stages I to II Cutaneous Melanoma.

Authors:  Laura Calomarde-Rees; Rosario García-Calatayud; Celia Requena Caballero; Esperanza Manrique-Silva; Víctor Traves; Zaida García-Casado; Virtudes Soriano; Rajiv Kumar; Eduardo Nagore
Journal:  JAMA Dermatol       Date:  2019-06-01       Impact factor: 10.282

3.  [Translated article] How Has the COVID-19 Pandemic and Lockdown Affected Breslow Thickness in Cutaneous Melanoma?

Authors:  J Sarriugarte Aldecoa-Otalora; L Loidi Pascual; A Córdoba Iturriagagoitia; J I Yanguas Bayona
Journal:  Actas Dermosifiliogr       Date:  2022-02-03

4.  Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab.

Authors:  A Lindauer; C R Valiathan; K Mehta; V Sriram; R de Greef; J Elassaiss-Schaap; D P de Alwis
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-11-08

5.  Limited impact of COVID-19-related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis.

Authors:  Tobias E Sangers; Marlies Wakkee; Eline C Kramer-Noels; Tamar Nijsten; Marieke W J Louwman; Elisabeth H Jaspars; Loes M Hollestein
Journal:  Br J Dermatol       Date:  2022-05-01       Impact factor: 11.113

6.  [How Has the COVID-19 Pandemic and Lockdown Affected Breslow Thickness in Cutaneous Melanoma?]

Authors:  J Sarriugarte Aldecoa-Otalora; L Loidi Pascual; A Córdoba Iturriagagoitia; J I Yanguas Bayona
Journal:  Actas Dermosifiliogr       Date:  2021-05-27

7.  [Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model].

Authors:  A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz-Pulido; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2020-05-11

8.  Automatic segmentation of skin cells in multiphoton data using multi-stage merging.

Authors:  Philipp Prinke; Jens Haueisen; Sascha Klee; Muhammad Qurhanul Rizqie; Eko Supriyanto; Karsten König; Hans Georg Breunig; Łukasz Piątek
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

9.  Tumor growth rate as a prognostic factor of acral melanoma in a Korean population.

Authors:  Gwanghyun Jo; Soo Ick Cho; Youngjoo Cho; Jungyoon Ohn; Je-Ho Mun
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.